Successful endoscopic sphincterotomy for choledocholithiasis in a patient with severe hemophilia A and inhibitors
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Journal of Gastroenterology"
DOI: 10.1007/s12328-018-0826-8
Abstract: Endoscopic sphincterotomy (ES) is a standard procedure for bile duct stone removal. However, the safety of ES in patients with hemophilia remains unknown. We treated a 46-year-old man who had choledocholithiasis and severe hemophilia A… read more here.
Keywords: severe hemophilia; choledocholithiasis; factor; endoscopic sphincterotomy ... See more keywords
Budget Impact of Emicizumab for Routine Prophylaxis of Bleeding Episodes in Patients With Hemophilia A With Inhibitors.
Sign Up to like & getrecommendations! Published in 2021 at "Value in health regional issues"
DOI: 10.1016/j.vhri.2021.07.003
Abstract: OBJECTIVES To examine the budget impact of emicizumab as prophylactic therapy in reducing the frequency of bleeding episodes in patients with hemophilia A with inhibitors in Malaysia. METHODS A budget impact model was built to… read more here.
Keywords: bleeding episodes; budget impact; budget; prophylaxis ... See more keywords
Patients with hemophilia A and inhibitors: prevention and evolving treatment paradigms
Sign Up to like & getrecommendations! Published in 2020 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2020.1739518
Abstract: ABSTRACT Introduction: Novel non-replacement therapies (e.g. emicizumab) have improved the management of patients with hemophilia A with and without inhibitors while introducing new challenges and increasing the complexity of clinical decision-making. Areas covered: Use of… read more here.
Keywords: patients hemophilia; inhibitor; use; inhibitors prevention ... See more keywords
The socioeconomic burden of patients affected by hemophilia with inhibitors
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Haematology"
DOI: 10.1111/ejh.13108
Abstract: Hemophilia is associated with a high financial burden on individuals, healthcare systems, and society. The development of inhibitors significantly increases the socioeconomic burden of the diseases. This study aimed to review and describe the burden… read more here.
Keywords: quality life; burden; patients affected; burden patients ... See more keywords
Neutralizing antidrug antibody to emicizumab in a patient with severe hemophilia A with inhibitors: New case with detailed laboratory evaluation
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14957
Abstract: Hemophilia A is an inherited bleeding disorder characterized by deficiency of the coagulation protein factor VIII. Development of clotting factor concentrates has resulted in an excellent prognosis for this historically fatal disease. However, neutralizing antidrug… read more here.
Keywords: severe hemophilia; neutralizing antidrug; antibody; patient severe ... See more keywords